beauvericin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, M; Li, J; Li, M; Liu, W; Qiao, Y; Song, Y; Wang, G; Yang, D; Yin, J; Zhao, Y | 1 |
| Chovolou, Y; Debbab, A; Hohlfeld, A; Proksch, P; Wätjen, W | 1 |
2 other study(ies) available for beauvericin and Liver Neoplasms
| Article | Year |
|---|---|
Beauvericin exerts an anti-tumor effect on hepatocellular carcinoma by inducing PI3K/AKT-mediated apoptosis.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Interleukin-2; Liver Neoplasms; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2023 |
The mycotoxin beauvericin induces apoptotic cell death in H4IIE hepatoma cells accompanied by an inhibition of NF-κB-activity and modulation of MAP-kinases.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Survival; Depsipeptides; Dose-Response Relationship, Drug; Enzyme Activation; HCT116 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; Mycotoxins; Necrosis; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Rats; Signal Transduction; src-Family Kinases; Time Factors | 2014 |